Drug-Target Interaction Using Deep Learning

Drug–target interaction (DTI) is the process of finding how a drug molecule connects or binds with a target, usually a protein, in the human body. This step is very important in drug discovery, because only when a drug binds to the right target can it be effective in treating a disease. Traditional laboratory experiments for DTI are slow, expensive, and require a lot of testing, which makes them unsuitable for screening thousands of drug candidates.Deep learning, a branch of artificial intelligence, has become a strong tool for predicting DTIs. It can automatically learn patterns from large datasets of known drugs and proteins. Instead of manually designing features, deep learning models use different architectures such as Convolutional Neural Networks (CNNs), Recurrent Neural Networks (RNNs), Graph Neural Networks (GNNs), and Transformers to extract meaningful information from drug sequences, molecular graphs, or protein data. These models are able to capture complex non-linear relationships, which makes them much more powerful than traditional machine learning methods.Using deep learning for DTI prediction helps researchers quickly identify promising drug–protein pairs, reduce laboratory costs, and speed up the process of developing new medicines. It also supports drug repurposing, where existing drugs can be tested for new diseases. Although challenges remain, such as interpretability and handling unseen drugs or targets, deep learning continues to push forward the accuracy and efficiency of DTI prediction, making it a central tool in modern drug discovery.